Leland Dennis
Psychiatry · Guthrie, OKNPI 1033155197
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,394 of the $3,194 with a category attached, or 75.0%. 14 manufacturers reported payments, led by Alkermes, Inc. at 33.9% of the total. 2023 is the largest year on record at $2,185, 5.7 times the $382 reported in 2021.
Across 150 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- Johnson & Johnson$786
- AbbVie$482
- Otsuka America Pharmaceutical, Inc.$147
- Teva Pharmaceuticals USA, Inc.$143
- Lundbeck LLC$132
- plus $424 from 8 others
Across 7 payments — averaging $222.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
What the payments were for
- Speaking & faculty fees$80025%
- Food & beverage$2,39475%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 13 | $1,081 |
| Johnson & Johnson | 33 | $786 |
| AbbVie | 63 | $482 |
| Otsuka America Pharmaceutical, Inc. | 8 | $147 |
| Teva Pharmaceuticals USA, Inc. | 9 | $143 |
| Lundbeck LLC | 6 | $132 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $108 |
| Indivior Inc. | 6 | $98 |
| Vanda Pharmaceuticals Inc. | 4 | $82 |
| Neurocrine Biosciences, Inc. | 3 | $64 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$3,200
- INVEGA SUSTENNA$379
- SPRAVATO$123
- CAPLYTA$108
How this compares
$3,194 in reported general payments places this provider in the 85th percentile of 328 psychiatry providers in Oklahoma.
Other psychiatry in Guthrie
- Robert MortonAda$1.9M
- Sarah LandTulsa$287K
- Willis HollowayOklahoma City$92K
- Adonis Al BotrosOklahoma City$73K
- Marvin PeytonOklahoma City$60K
- Charles LesterMuskogee$39K
- Josephine DeguzmanOklahoma City$38K
- Jennifer MorrisEdmond$26K
- Julia IrwinNorman$16K
- Bradley McClureTulsa$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.